Nicola Klein to Diphtheria-Tetanus-Pertussis Vaccine
This is a "connection" page, showing publications Nicola Klein has written about Diphtheria-Tetanus-Pertussis Vaccine.
Connection Strength
1.869
-
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine. 2016 07 29; 34(35):4172-4179.
Score: 0.544
-
Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012 Sep 13; 367(11):1012-9.
Score: 0.418
-
Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization. Pediatr Infect Dis J. 2010 Jul; 29(7):613-7.
Score: 0.359
-
Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants. Pediatr Infect Dis J. 2017 02; 36(2):202-208.
Score: 0.142
-
Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis. Clin Infect Dis. 2016 Dec 01; 63(11):1456-1462.
Score: 0.138
-
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.116
-
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
Score: 0.107
-
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial. Vaccine. 2021 03 05; 39(10):1534-1543.
Score: 0.046